InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Polverino Anthony J., Directeur Scientifique. Officer active across 2 companies, notably Zymeworks Inc.. Cumulatively, 12 disclosures have been recorded. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations12 total
03,882 shares0
Common Stock
SEC:0001104659-22-011390·
03,882 shares0
Common Stock
SEC:0001104659-22-011390:0·
€91374 shares@ €12.33970.0000% mcap1.2% of flow
Common Shares
SEC:0000899243-22-001424·
€91374 shares@ €12.33970.0000% mcap0.6% of flow
Common Shares
SEC:0000899243-22-001424:0·
02,000 shares0
Common Stock
SEC:0001104659-21-151215·
02,000 shares0
Common Stock
SEC:0001104659-21-151215:0·
02,216 shares0
Common Stock
SEC:0001104659-21-148751·
02,216 shares0
Common Stock
SEC:0001104659-21-148751:0·
€62,2344,900 shares@ €12.70080.0031% mcap83.6% of flow
Common Shares
SEC:0000899243-21-034985·
€62,2344,900 shares@ €12.70080.0031% mcap41.8% of flow
Common Shares
SEC:0000899243-21-034985:0·
€11,323454 shares@ €24.93970.0006% mcap15.2% of flow
Common Shares
SEC:0000899243-21-027914·
€11,323454 shares@ €24.93970.0006% mcap7.6% of flow
Common Shares
SEC:0000899243-21-027914:0·
12 of 12 declarations
About Polverino Anthony J.
Anthony J. Polverino is the Chief Scientific Officer and Board Member at Zymeworks Inc. and Brainstorm Cell Therapeutics Inc. He is responsible for scientific leadership and innovation within both companies. With a strong background in the biopharmaceutical sector, he plays a key role in developing new therapies and products. His expertise contributes to the strategic direction of the companies.
